Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard Neil Channick, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Rahaghi FN, Winkler T, Kohli P, Nardelli P, Martí-Fuster B, Ross JC, Radhakrishnan R, Blackwater T, Ash SY, de La Bruere I, Diaz AA, Channick RN, Harris RS, Washko GR, San José Estépar R. Quantification of the Pulmonary Vascular Response to Inhaled Nitric Oxide Using Noncontrast Computed Tomography Imaging. Circ Cardiovasc Imaging. 2019 Dec; 12(1):e008338. PMID: 30632391.
    Citations:    Fields:    
  2. Kohli P, Kelly VJ, Kehl EG, Rodriguez-Lopez J, Hibbert KA, Kone M, Systrom DM, Waxman AB, Venegas JG, Channick R, Winkler T, Harris RS. Perfusion Imaging Distinguishes Exercise Pulmonary Arterial Hypertension at Rest. Am J Respir Crit Care Med. 2019 Jun 01; 199(11):1438-1441. PMID: 30811948.
    Citations:    
  3. Chin KM, Rubin LJ, Channick R, Di Scala L, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension. Circulation. 2019 May 21; 139(21):2440-2450. PMID: 30982349.
    Citations:    
  4. Kratzert WB, Boyd EK, Saggar R, Channick R. Critical Care of Patients After Pulmonary Thromboendarterectomy. J Cardiothorac Vasc Anesth. 2019 Mar 08. PMID: 30948200.
    Citations:    
  5. Channick CL, Channick RN. Use of Endobronchial Ultrasound for Bedside Diagnosis of Acute Pulmonary Embolism in a Critically Ill Patient. Chest. 2019 Mar; 155(3):651-652. PMID: 30846074.
    Citations:    
  6. Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019 Jan; 53(1). PMID: 30545971.
    Citations:    Fields:    
  7. Beghetti M, Channick RN, Chin KM, Di Scala L, Gaine S, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Galiè N. Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study. Eur J Heart Fail. 2019 03; 21(3):352-359. PMID: 30632656.
    Citations:    Fields:    
  8. Witkin A, Wilcox SR, Chang Y, Huang F, Dudzinski D, Zheng H, Channick R, Kabrhel C. Impact of chronic right ventricular pressure overload in short-term outcomes of acute pulmonary embolism: A retrospective analysis. J Crit Care. 2019 Jun; 51:1-5. PMID: 30673622.
    Citations:    Fields:    
  9. Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I, Sundt T, Witkin A, Rodriguez-Lopez J, Parry BA, Harshbarger S, Hariharan P, Kabrhel C. Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan; 47(1):41. PMID: 30506351.
    Citations:    Fields:    
  10. Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I, Sundt T, Witkin A, Rodriguez-Lopez J, Parry BA, Harshbarger S, Hariharan P, Kabrhel C. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan; 47(1):31-40. PMID: 30242551.
    Citations:    Fields:    
  11. Dalia AA, Streckenbach S, Andrawes M, Channick R, Wright C, Fitzsimons M. Management of Pulmonary Hemorrhage Complicating Pulmonary Thromboendarterectomy. Front Med (Lausanne). 2018; 5:326. PMID: 30525040.
    Citations:    
  12. Chin KM, Gomberg-Maitland M, Channick RN, Cuttica MJ, Fischer A, Frantz RP, Hunsche E, Kleinman L, McConnell JW, McLaughlin VV, Miller CE, Zamanian RT, Zastrow MS, Badesch DB. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial. Chest. 2018 Oct; 154(4):848-861. PMID: 29705220.
    Citations:    Fields:    
  13. Souza R, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Torbicki A, Rubin LJ, Simonneau G. Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial. PLoS One. 2018; 13(3):e0193226. PMID: 29590122.
    Citations:    Fields:    Translation:Humans
  14. McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N. Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality. J Am Coll Cardiol. 2018 Feb 20; 71(7):752-763. PMID: 29447737.
    Citations: 3     Fields:    
  15. Coghlan JG, Channick R, Chin K, Di Scala L, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Gaine S. Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study. Am J Cardiovasc Drugs. 2018 Feb; 18(1):37-47. PMID: 29307087.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  16. Sihag S, Le B, Witkin AS, Rodriguez-Lopez JM, Villavicencio MA, Vlahakes GJ, Channick RN, Wright CD. Quantifying the learning curve for pulmonary thromboendarterectomy. J Cardiothorac Surg. 2017 Dec 28; 12(1):121. PMID: 29284512.
    Citations:    Fields:    Translation:Humans
  17. McNeill JN, Witkin AS, Chang Y, Kabrhel C, Channick RN. Does the Time of Day a Pulmonary Embolism Response Team Is Activated Affect Time to Intervention or Outcome? Chest. 2017 12; 152(6):1353-1354. PMID: 29223267.
    Citations:    Fields:    
  18. Talwar A, Garcia JGN, Tsai H, Moreno M, Lahm T, Zamanian RT, Machado R, Kawut SM, Selej M, Mathai S, D'Anna LH, Sahni S, Rodriquez EJ, Channick R, Fagan K, Gray M, Armstrong J, Rodriguez Lopez J, de Jesus Perez V. Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2017 10 15; 196(8):e32-e47. PMID: 29028375.
    Citations: 1     Fields:    Translation:Humans
  19. Preston IR, Channick RN, Chin K, Di Scala L, Farber HW, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF, Rubin LJ. Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study. J Heart Lung Transplant. 2018 Mar; 37(3):401-408. PMID: 29096938.
    Citations: 1     Fields:    
  20. Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galiè N, Ghofrani HA, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Hoeper MM. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. Eur Respir J. 2017 08; 50(2). PMID: 28818881.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  21. Liu D, Sindhu K, Witkin A, Patel L, Channick R. Pulmonary Hypertension in a Patient with Hereditary Hemorrhagic Telangiectasia. R I Med J (2013). 2017 Aug 01; 100(8):29-31. PMID: 28759897.
    Citations:    Fields:    Translation:Humans
  22. DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation. 2017 07; 101(7):1609-1615. PMID: 28207639.
    Citations: 1     Fields:    Translation:Humans
  23. Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani HA, Le Brun FO, Mehta S, Perchenet L, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. Eur Heart J. 2017 04 14; 38(15):1147-1155. PMID: 28329315.
    Citations: 3     Fields:    Translation:Humans
  24. Rodriguez-Lopez J, Channick R. The Pulmonary Embolism Response Team: What Is the Ideal Model? Semin Respir Crit Care Med. 2017 02; 38(1):51-55. PMID: 28208198.
    Citations:    Fields:    Translation:HumansPHPublic Health
  25. Jain CC, Chang Y, Kabrhel C, Giri J, Channick R, Rodriguez-Lopez J, Rosovsky RP, Fogerty A, Rosenfield K, Jaff MR, Weinberg I. Impact of Pulmonary Arterial Clot Location on Pulmonary Embolism Treatment and Outcomes (90 Days). Am J Cardiol. 2017 03 01; 119(5):802-807. PMID: 28153347.
    Citations: 1     Fields:    Translation:Humans
  26. DuBrock HM, Rodriguez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Ananth Karumanchi S. Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension. Pulm Circ. 2016 Dec; 6(4):498-507. PMID: 28090291.
    Citations: 1     
  27. Olsson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016 Dec; 25(142):431-437. PMID: 27903665.
    Citations:    Fields:    Translation:Humans
  28. Berra L, Rodriguez-Lopez J, Rezoagli E, Yu B, Fisher DF, Semigran MJ, Bloch DB, Channick RN, Zapol WM. Electric Plasma-generated Nitric Oxide: Hemodynamic Effects in Patients with Pulmonary Hypertension. Am J Respir Crit Care Med. 2016 11 01; 194(9):1168-1170. PMID: 27797618.
    Citations: 1     Fields:    Translation:Humans
  29. Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. Chest. 2017 Jan; 151(1):106-118. PMID: 27671974.
    Citations: 5     Fields:    Translation:Humans
  30. Tamura Y, Channick RN. New paradigm for pulmonary arterial hypertension treatment. Curr Opin Pulm Med. 2016 09; 22(5):429-33. PMID: 27434819.
    Citations: 1     Fields:    Translation:Humans
  31. Humbert M, Channick RN. Pulmonary hypertension. Curr Opin Pulm Med. 2016 09; 22(5):399. PMID: 27428648.
    Citations:    Fields:    
  32. Pepke-Zaba J, Jais X, Channick R. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016 07; 13 Suppl 3:S248-54. PMID: 27571006.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  33. Tapson VF, Platt DM, Xia F, Teal SA, de la Orden M, Divers CH, Satler CA, Joish VN, Channick RN. Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM Study. Am J Med. 2016 09; 129(9):978-985.e2. PMID: 27046247.
    Citations: 2     Fields:    Translation:Humans
  34. Kabrhel C, Rosovsky R, Channick R, Jaff MR, Weinberg I, Sundt T, Dudzinski DM, Rodriguez-Lopez J, Parry BA, Harshbarger S, Chang Y, Rosenfield K. A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism. Chest. 2016 08; 150(2):384-93. PMID: 27006156.
    Citations: 13     Fields:    Translation:Humans
  35. Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV. Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2015 Dec 24; 373(26):2522-33. PMID: 26699168.
    Citations: 71     Fields:    Translation:HumansCTClinical Trials
  36. Parikh VN, Park J, Nikolic I, Channick R, Yu PB, De Marco T, Hsue PY, Chan SY. Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection. J Acquir Immune Defic Syndr. 2015 Nov 01; 70(3):236-41. PMID: 26473639.
    Citations: 2     Fields:    Translation:Humans
  37. Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BK, Sitbon O, Souza R, Torbicki A, Rubin LJ. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. Eur Respir J. 2015 Dec; 46(6):1711-20. PMID: 26493786.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  38. Wilcox SR, Kabrhel C, Channick RN. Pulmonary Hypertension and Right Ventricular Failure in Emergency Medicine. Ann Emerg Med. 2015 Dec; 66(6):619-28. PMID: 26342901.
    Citations: 3     Fields:    Translation:Humans
  39. LeVarge BL, Channick RN. The changing paradigm in pulmonary hypertension trials: longer duration, new endpoints. Curr Opin Pulm Med. 2015 Sep; 21(5):438-45. PMID: 26176969.
    Citations:    Fields:    Translation:Humans
  40. DuBrock HM, Kradin RL, Rodriguez-Lopez JM, Channick RN. Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing. Pulm Circ. 2015 Sep; 5(3):580-6. PMID: 26401260.
    Citations:    
  41. Selej M, Romero AJ, Channick RN, Clozel M. Development of macitentan for the treatment of pulmonary arterial hypertension. Ann N Y Acad Sci. 2015 Nov; 1358:68-81. PMID: 26291180.
    Citations: 1     Fields:    Translation:Humans
  42. Witkin AS, Channick RN. Chronic Thromboembolic Pulmonary Hypertension: the End Result of Pulmonary Embolism. Curr Cardiol Rep. 2015 Aug; 17(8):63. PMID: 26099554.
    Citations: 3     Fields:    Translation:Humans
  43. McLaughlin V, Channick RN, Ghofrani HA, Lemarié JC, Naeije R, Packer M, Souza R, Tapson VF, Tolson J, Al Hiti H, Meyer G, Hoeper MM. Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension. Eur Respir J. 2015 Aug; 46(2):405-13. PMID: 26113687.
    Citations: 36     Fields:    Translation:Humans
  44. Sheu EG, Channick R, Gee DW. Improvement in severe pulmonary hypertension in obese patients after laparoscopic gastric bypass or sleeve gastrectomy. Surg Endosc. 2016 Feb; 30(2):633-637. PMID: 26091991.
    Citations: 2     Fields:    Translation:Humans
  45. Afilalo J, Grapsa J, Nihoyannopoulos P, Beaudoin J, Gibbs JS, Channick RN, Langleben D, Rudski LG, Hua L, Handschumacher MD, Picard MH, Levine RA. Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertension. Circ Cardiovasc Imaging. 2015 May; 8(5). PMID: 25977303.
    Citations: 2     Fields:    Translation:Humans
  46. DuBrock HM, Channick RN, Krowka MJ. What's new in the treatment of portopulmonary hypertension? Expert Rev Gastroenterol Hepatol. 2015 Jul; 9(7):983-92. PMID: 25882070.
    Citations: 1     Fields:    Translation:Humans
  47. Channick RN, Delcroix M, Ghofrani HA, Hunsche E, Jansa P, Le Brun FO, Mehta S, Pulido T, Rubin LJ, Sastry BK, Simonneau G, Sitbon O, Souza R, Torbicki A, Galiè N. Effect of macitentan on hospitalizations: results from the SERAPHIN trial. JACC Heart Fail. 2015 Jan; 3(1):1-8. PMID: 25457902.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  48. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. [Chronic thromboembolic pulmonary hypertension]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:119-29. PMID: 25697039.
    Citations:    Fields:    
  49. LeVarge BL, Channick RN. Chronic thromboembolic pulmonary hypertension: evolution in management. Curr Opin Pulm Med. 2014 Sep; 20(5):400-8. PMID: 25093673.
    Citations: 1     Fields:    Translation:Humans
  50. DuBrock HM, Channick RN. Macitentan for the treatment of pulmonary arterial hypertension. Expert Rev Respir Med. 2014 Aug; 8(4):393-9. PMID: 24998329.
    Citations:    Fields:    Translation:Humans
  51. LeVarge BL, Pomerantsev E, Channick RN. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J. 2014 Aug; 44(2):425-34. PMID: 24925918.
    Citations: 9     Fields:    Translation:Humans
  52. Saukkonen K, Tan TC, Sharma A, Channick RN, Murali MR, Zukerberg LR. Case records of the Massachusetts General Hospital. Case 9-2014. A 34-year-old woman with increasing dyspnea. N Engl J Med. 2014 Mar 20; 370(12):1149-57. PMID: 24645948.
    Citations:    Fields:    Translation:Humans
  53. Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J, Weinberg I, Donaldson C, Narayan R, Rassi AN, Kabrhel C. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995). 2014 Feb; 42(1):31-7. PMID: 24566594.
    Citations: 14     Fields:    Translation:Humans
  54. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D92-9. PMID: 24355646.
    Citations: 62     Fields:    Translation:HumansAnimals
  55. Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, Hachulla E, Humbert M, Langleben D, Mathai SC, Saggar R, Visovatti S, Altorok N, Townsend W, FitzGerald J, McLaughlin VV. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013 Dec; 65(12):3194-201. PMID: 24022584.
    Citations: 24     Fields:    Translation:Humans
  56. Channick R, Preston I, Klinger JR. Oral therapies for pulmonary arterial hypertension: endothelin receptor antagonists and phosphodiesterase-5 inhibitors. Clin Chest Med. 2013 Dec; 34(4):811-24. PMID: 24267306.
    Citations: 2     Fields:    Translation:Humans
  57. Kabrhel C, Jaff MR, Channick RN, Baker JN, Rosenfield K. A multidisciplinary pulmonary embolism response team. Chest. 2013 Nov; 144(5):1738-1739. PMID: 24189880.
    Citations: 12     Fields:    Translation:Humans
  58. Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013 Aug 29; 369(9):809-18. PMID: 23984728.
    Citations: 168     Fields:    Translation:HumansCTClinical Trials
  59. Sise ME, Courtwright AM, Channick RN. Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int. 2013 Oct; 84(4):682-92. PMID: 23739239.
    Citations: 22     Fields:    Translation:Humans
  60. Channick RN. Combination therapy in pulmonary arterial hypertension. Am J Cardiol. 2013 Apr 16; 111(8 Suppl):16C-20C. PMID: 23558025.
    Citations: 4     Fields:    Translation:Humans
  61. Channick RN, Frantz RP, Kawut SM, Palevsky H, Tumuluri R, Sulica R, Lauto PO, Benton WW, de Boisblanc B. A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost. Pulm Circ. 2013 Apr; 3(2):381-8. PMID: 24015339.
    Citations: 5     
  62. Malhotra R, Paskin-Flerlage S, Zamanian RT, Zimmerman P, Schmidt JW, Deng DY, Southwood M, Spencer R, Lai CS, Parker W, Channick RN, Morrell NW, Elliott CG, Yu PB. Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension. Pulm Circ. 2013 Apr; 3(2):369-80. PMID: 24015338.
    Citations: 8     
  63. Bourge RC, Tapson VF, Safdar Z, Benza RL, Channick RN, Rosenzweig EB, Shapiro S, White RJ, McSwain CS, Gotzkowsky SK, Nelsen AC, Rubin LJ. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Ther. 2013 Feb; 31(1):38-44. PMID: 22970909.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  64. McLaughlin VV, Langer A, Tan M, Clements PJ, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest. 2013 Feb 01; 143(2):324-332. PMID: 22910999.
    Citations: 15     Fields:    Translation:Humans
  65. Kovach AE, Cheng GZ, Channick CL, Channick RN, Muniappan A, Gaissert HA, Kradin RL. Postradiofrequency ablation inflammatory pseudotumor associated with pulmonary venoocclusive disease: case report and review of the literature. Ann Diagn Pathol. 2013 Oct; 17(5):466-9. PMID: 23352326.
    Citations:    Fields:    Translation:Humans
  66. LeVarge BL, Channick RN. Inhaled treprostinil for the treatment of pulmonary arterial hypertension. Expert Rev Respir Med. 2012 Jun; 6(3):255-65. PMID: 22788940.
    Citations: 2     Fields:    Translation:Humans
  67. Channick RN, Lorenzo ME, Wu CC, Hoang MP. Case records of the Massachusetts General Hospital. Case 11-2012. A 60-year-old man with weakness, rash, and renal failure. N Engl J Med. 2012 Apr 12; 366(15):1434-43. PMID: 22494124.
    Citations:    Fields:    Translation:Humans
  68. Barst RJ, Channick R, Ivy D, Goldstein B. Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulm Circ. 2012 Apr-Jun; 2(2):139-47. PMID: 22837854.
    Citations: 14     
  69. Channick RN, Voswinckel R, Rubin LJ. Inhaled treprostinil: a therapeutic review. Drug Des Devel Ther. 2012; 6:19-28. PMID: 22291467.
    Citations: 4     Fields:    Translation:Humans
  70. Benza RL, Seeger W, McLaughlin VV, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubin LJ. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant. 2011 Dec; 30(12):1327-33. PMID: 22055098.
    Citations: 18     Fields:    Translation:Humans
  71. Clements PJ, Tan M, McLaughlin VV, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ, Langer A. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis. 2012 Feb; 71(2):249-52. PMID: 21998119.
    Citations: 20     Fields:    Translation:Humans
  72. Kerr KM, Auger WR, Marsh JJ, Devendra G, Spragg RG, Kim NH, Channick RN, Jamieson SW, Madani MM, Manecke GR, Roth DM, Shragg GP, Fedullo PF. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest. 2012 Jan; 141(1):27-35. PMID: 21835900.
    Citations: 4     Fields:    Translation:Humans
  73. McLaughlin VV, Benza RL, Rubin LJ, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubenfire M, Seeger W. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol. 2010 May 04; 55(18):1915-22. PMID: 20430262.
    Citations: 87     Fields:    Translation:Humans
  74. Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A, Martinez FJ, Naeije R, Olschewski H, Pepke-Zaba J, Redfield MM, Robbins IM, Souza R, Torbicki A, McGoon M. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009 Jun 30; 54(1 Suppl):S85-96. PMID: 19555862.
    Citations: 65     Fields:    Translation:Humans
  75. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009 Jun 30; 54(1 Suppl):S43-54. PMID: 19555858.
    Citations: 492     Fields:    Translation:Humans
  76. Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JX. A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation. 2009 May 05; 119(17):2313-22. PMID: 19380626.
    Citations: 58     Fields:    Translation:HumansCells
  77. Rothman A, Galindo A, Channick R, Blanchard D. Amplatzer device closure of a tortuous Gerbode (left ventricle-to-right atrium) defect complicated by transient hemolysis in an octogenarian. J Invasive Cardiol. 2008 Sep; 20(9):E273-6. PMID: 18762687.
    Citations: 7     Fields:    Translation:Humans
  78. Chin KM, Channick RN, de Lemos JA, Kim NH, Torres F, Rubin LJ. Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension. Chest. 2009 Jan; 135(1):130-136. PMID: 18719056.
    Citations: 12     Fields:    Translation:Humans
  79. Hennigan S, Channick RN, Silverman GJ. Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report. Lupus. 2008 Aug; 17(8):754-6. PMID: 18625655.
    Citations: 5     Fields:    Translation:Humans
  80. Desai SA, Channick RN. Exercise in patients with pulmonary arterial hypertension. J Cardiopulm Rehabil Prev. 2008 Jan-Feb; 28(1):12-6. PMID: 18277824.
    Citations: 7     Fields:    Translation:Humans
  81. Chin KM, Channick RN, Kim NH, Rubin LJ. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels. Chest. 2007 Sep; 132(3):786-92. PMID: 17646224.
    Citations:    Fields:    Translation:Humans
  82. McLaughlin VV, Channick R. Sickle cell disease-associated pulmonary hypertension: a coat of many colors. Am J Respir Crit Care Med. 2007 Jun 15; 175(12):1218-9. PMID: 17545455.
    Citations: 1     Fields:    Translation:Humans
  83. Remillard CV, Tigno DD, Platoshyn O, Burg ED, Brevnova EE, Conger D, Nicholson A, Rana BK, Channick RN, Rubin LJ, O'connor DT, Yuan JX. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol. 2007 May; 292(5):C1837-53. PMID: 17267549.
    Citations: 53     Fields:    Translation:HumansAnimalsCells
  84. Chin KM, Channick RN, Rubin LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest. 2006 Dec; 130(6):1657-63. PMID: 17166979.
    Citations: 33     Fields:    Translation:Humans
  85. Channick RN, Olschewski H, Seeger W, Staub T, Voswinckel R, Rubin LJ. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol. 2006 Oct 03; 48(7):1433-7. PMID: 17010807.
    Citations: 26     Fields:    Translation:HumansCTClinical Trials
  86. Walker AM, Langleben D, Korelitz JJ, Rich S, Rubin LJ, Strom BL, Gonin R, Keast S, Badesch D, Barst RJ, Bourge RC, Channick R, Frost A, Gaine S, McGoon M, McLaughlin V, Murali S, Oudiz RJ, Robbins IM, Tapson V, Abenhaim L, Constantine G. Temporal trends and drug exposures in pulmonary hypertension: an American experience. Am Heart J. 2006 Sep; 152(3):521-6. PMID: 16923424.
    Citations: 14     Fields:    Translation:Humans
  87. McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006 Dec 01; 174(11):1257-63. PMID: 16946127.
    Citations: 89     Fields:    Translation:Humans
  88. Bartolome SD, Channick RN. Sildenafil for pulmonary arterial hypertension. Future Cardiol. 2006 Mar; 2(2):137-43. PMID: 19804069.
    Citations:    Fields:    
  89. Lee SH, Channick RN. Endothelin antagonism in pulmonary arterial hypertension. Semin Respir Crit Care Med. 2005 Aug; 26(4):402-8. PMID: 16121317.
    Citations: 9     Fields:    Translation:Humans
  90. Humbert M, Barst RJ, Robbins IM, Channick RN, Galiè N, Boonstra A, Rubin LJ, Horn EM, Manes A, Simonneau G. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J. 2004 Sep; 24(3):353-9. PMID: 15358690.
    Citations: 84     Fields:    Translation:HumansCTClinical Trials
  91. Channick R, Williamson TL. Diagnosis and treatment of pulmonary arterial hypertension. Cardiol Clin. 2004 Aug; 22(3):441-52, vii. PMID: 15302363.
    Citations: 3     Fields:    Translation:Humans
  92. Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul; 126(1 Suppl):63S-71S. PMID: 15249495.
    Citations: 19     Fields:    Translation:Humans
  93. Ghofrani HA, Pepke-Zaba J, Barbera JA, Channick R, Keogh AM, Gomez-Sanchez MA, Kneussl M, Grimminger F. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S):68S-72S. PMID: 15194181.
    Citations: 22     Fields:    Translation:HumansAnimals
  94. Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ. Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S):62S-67S. PMID: 15194180.
    Citations: 29     Fields:    Translation:Humans
  95. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004 Apr; 23(4):595-600. PMID: 15083760.
    Citations: 13     Fields:    Translation:Humans
  96. Chin K, Channick R. Bosentan. Expert Rev Cardiovasc Ther. 2004 Mar; 2(2):175-82. PMID: 15151466.
    Citations: 1     Fields:    Translation:Humans
  97. Yung GL, Fedullo PF, Kinninger K, Johnson W, Channick RN. Comparison of impedance cardiography to direct Fick and thermodilution cardiac output determination in pulmonary arterial hypertension. Congest Heart Fail. 2004 Mar-Apr; 10(2 Suppl 2):7-10. PMID: 15073478.
    Citations: 6     Fields:    Translation:Humans
  98. Kim NH, Fesler P, Channick RN, Knowlton KU, Ben-Yehuda O, Lee SH, Naeije R, Rubin LJ. Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation. 2004 Jan 06; 109(1):18-22. PMID: 14699009.
    Citations: 17     Fields:    Translation:Humans
  99. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003 Nov; 76(5):1457-62; discussion 1462-4. PMID: 14602267.
    Citations: 94     Fields:    Translation:Humans
  100. Kim NH, Channick RN, Rubin LJ. Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension. Chest. 2003 Oct; 124(4):1612-5. PMID: 14555600.
    Citations: 10     Fields:    Translation:Humans
  101. Tulevski II, Bresser P, Hirsch A, Groenink M, Channick RN, Jamieson SW, Mulder BJ. Decreased plasma neurohormones and improved cardiac performance after surgical treatment of chronic pulmonary embolism. Ann Thorac Surg. 2003 Jul; 76(1):287-90. PMID: 12842565.
    Citations: 2     Fields:    Translation:Humans
  102. Sitbon O, Badesch DB, Channick RN, Frost A, Robbins IM, Simonneau G, Tapson VF, Rubin LJ. Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest. 2003 Jul; 124(1):247-54. PMID: 12853530.
    Citations: 42     Fields:    Translation:Humans
  103. Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003 Jun 18; 41(12):2119-25. PMID: 12821234.
    Citations: 76     Fields:    Translation:HumansCTClinical Trials
  104. Galiè N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, Espinola-Zavaleta N, Rocchi G, Manes A, Frantz R, Kurzyna M, Nagueh SF, Barst R, Channick R, Dujardin K, Kronenberg A, Leconte I, Rainisio M, Rubin L. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003 Apr 16; 41(8):1380-6. PMID: 12706935.
    Citations: 52     Fields:    Translation:HumansCTClinical Trials
  105. Fesler P, Pagnamenta A, Vachiéry JL, Brimioulle S, Abdel Kafi S, Boonstra A, Delcroix M, Channick RN, Rubin LJ, Naeije R. Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J. 2003 Jan; 21(1):31-6. PMID: 12570105.
    Citations: 9     Fields:    Translation:Humans
  106. Yung GL, Kriett JM, Jamieson SW, Johnson FW, Newhart J, Kinninger K, Channick RN. Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation. J Heart Lung Transplant. 2001 Nov; 20(11):1224-7. PMID: 11704484.
    Citations: 2     Fields:    Translation:Humans
  107. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet. 2001 Oct 06; 358(9288):1119-23. PMID: 11597664.
    Citations: 238     Fields:    Translation:HumansCTClinical Trials
  108. Robbins IM, Barst RJ, Channick RN, Rubin LJ. Pulmonary vasoreactivity in PPH. J Am Coll Cardiol. 2001 Oct; 38(4):1267-8. PMID: 11587028.
    Citations: 1     Fields:    Translation:Humans
  109. Channick RN, Rubin LJ. New and experimental therapies for pulmonary hypertension. Clin Chest Med. 2001 Sep; 22(3):539-45. PMID: 11590847.
    Citations: 5     Fields:    Translation:HumansAnimals
  110. Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2001 Sep; 22(3):561-81. PMID: 11590849.
    Citations: 7     Fields:    Translation:HumansAnimals
  111. Bailey CL, Channick RN, Rubin LJ. A new era in the treatment of primary pulmonary hypertension. Heart. 2001 Mar; 85(3):251-2. PMID: 11179256.
    Citations:    Fields:    Translation:HumansAnimals
  112. Channick R, Badesch DB, Tapson VF, Simonneau G, Robbins I, Frost A, Roux S, Rainisio M, Bodin F, Rubin LJ. Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study. J Heart Lung Transplant. 2001 Feb; 20(2):262-263. PMID: 11250530.
    Citations: 14     Fields:    
  113. Bailey CL, Channick RN, Auger WR, Fedullo PF, Kerr KM, Yung GL, Rubin LJ. "High probability" perfusion lung scans in pulmonary venoocclusive disease. Am J Respir Crit Care Med. 2000 Nov; 162(5):1974-8. PMID: 11069842.
    Citations: 7     Fields:    Translation:Humans
  114. Kerr KM, Auger WR, Marsh JJ, Comito RM, Fedullo RL, Smits GJ, Kapelanski DP, Fedullo PF, Channick RN, Jamieson SW, Moser KM. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 2000 Jul; 162(1):14-20. PMID: 10903213.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  115. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Exp Lung Res. 2000 Jun; 26(4):287-301. PMID: 10923246.
    Citations: 4     Fields:    Translation:AnimalsCells
  116. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J. 2000 Apr; 15(4):640-8. PMID: 10780753.
    Citations: 13     Fields:    Translation:Animals
  117. Channick RN, Rubin LJ. Combination therapy for pulmonary hypertension: a glimpse into the future? Crit Care Med. 2000 Mar; 28(3):896-7. PMID: 10752856.
    Citations: 3     Fields:    Translation:HumansAnimals
  118. Fedullo PF, Rubin LJ, Kerr KM, Auger WR, Channick RN. The natural history of acute and chronic thromboembolic disease: the search for the missing link. Eur Respir J. 2000 Mar; 15(3):435-7. PMID: 10759432.
    Citations: 9     Fields:    Translation:Humans
  119. Bergin CJ, Hauschildt JP, Brown MA, Channick RN, Fedullo PF. Identifying the cause of unilateral hypoperfusion in patients suspected to have chronic pulmonary thromboembolism: diagnostic accuracy of helical CT and conventional angiography. Radiology. 1999 Dec; 213(3):743-9. PMID: 10580948.
    Citations: 2     Fields:    Translation:Humans
  120. Mo M, Kapelanski DP, Mitruka SN, Auger WR, Fedullo PF, Channick RN, Kerr K, Archibald C, Jamieson SW. Reoperative pulmonary thromboendarterectomy. Ann Thorac Surg. 1999 Nov; 68(5):1770-6; discussion 1776-7. PMID: 10585057.
    Citations: 8     Fields:    Translation:Humans
  121. Rothman A, Sklansky MS, Lucas VW, Kashani IA, Shaughnessy RD, Channick RN, Auger WR, Fedullo PF, Smith CM, Kriett JM, Jamieson SW. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol. 1999 Sep 15; 84(6):682-6. PMID: 10498139.
    Citations: 19     Fields:    Translation:Humans
  122. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, Kapelanski DP, Watt CN, Moser KM. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999 Aug; 160(2):523-8. PMID: 10430723.
    Citations: 37     Fields:    Translation:Humans
  123. Auger WR, Channick RN, Kerr KM, Fedullo PF. Evaluation of patients with suspected chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 1999 Apr; 11(2):179-90. PMID: 10378862.
    Citations: 4     Fields:    Translation:Humans
  124. Yung GL, Channick RN, Fedullo PF, Auger WR, Kerr KM, Jamieson SW, Kapelanski DP, Moser KM. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit Care Med. 1998 May; 157(5 Pt 1):1690-3. PMID: 9603156.
    Citations: 11     Fields:    Translation:Humans
  125. Bergin CJ, Hauschildt J, Rios G, Belezzuoli EV, Huynh T, Channick RN. Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension. AJR Am J Roentgenol. 1997 Jun; 168(6):1549-55. PMID: 9168722.
    Citations: 3     Fields:    Translation:Humans
  126. Wilson WC, Kapelanski DP, Benumof JL, Newhart 2nd JW, Johnson FW, Channick RN. Inhaled nitric oxide (40 ppm) during one-lung ventilation, in the lateral decubitus position, does not decrease pulmonary vascular resistance or improve oxygenation in normal patients. J Cardiothorac Vasc Anesth. 1997 Apr; 11(2):172-6. PMID: 9105988.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  127. Bradley SP, Auger WR, Moser KM, Fedullo PF, Channick RN, Bloor CM. Right ventricular pathology in chronic pulmonary hypertension. Am J Cardiol. 1996 Sep 01; 78(5):584-7. PMID: 8806351.
    Citations: 4     Fields:    Translation:Humans
  128. Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, Moser KM. Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest. 1996 Aug; 110(2):399-403. PMID: 8697841.
    Citations: 5     Fields:    Translation:Humans
  129. Hirsch AM, Moser KM, Auger WR, Channick RN, Fedullo PF. Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? Am J Respir Crit Care Med. 1996 Aug; 154(2 Pt 1):491-6. PMID: 8756827.
    Citations: 3     Fields:    Translation:Humans
  130. Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR, Fedullo PF, Moser KM. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest. 1996 Jun; 109(6):1545-9. PMID: 8769509.
    Citations: 21     Fields:    Translation:Humans
  131. Fedullo PF, Auger WR, Channick RN, Moser KM, Jamieson SW. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 1995 Jun; 16(2):353-74. PMID: 7656546.
    Citations: 4     Fields:    Translation:Humans
  132. Channick RN, Newhart JW, Johnson FW, Moser KM. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs. A practical nitric oxide delivery and monitoring system. Chest. 1994 Jun; 105(6):1842-7. PMID: 8205886.
    Citations: 2     Fields:    Translation:Animals
  133. Channick RN, Hoch RC, Newhart JW, Johnson FW, Smith CM. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):811-4. PMID: 8118653.
    Citations: 9     Fields:    Translation:Humans
  134. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Tarazi RY, Moser KM. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg. 1993 Jul; 106(1):116-26; discussion 126-7. PMID: 8320990.
    Citations: 30     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Channick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (386)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.